आईएसएसएन: 2576-3881

जर्नल ऑफ़ साइटोकाइन बायोलॉजी

खुला एक्सेस

हमारा समूह 1000 से अधिक वैज्ञानिक सोसायटी के सहयोग से हर साल संयुक्त राज्य अमेरिका, यूरोप और एशिया में 3000+ वैश्विक सम्मेलन श्रृंखला कार्यक्रम आयोजित करता है और 700+ ओपन एक्सेस जर्नल प्रकाशित करता है जिसमें 50000 से अधिक प्रतिष्ठित व्यक्तित्व, प्रतिष्ठित वैज्ञानिक संपादकीय बोर्ड के सदस्यों के रूप में शामिल होते हैं।

ओपन एक्सेस जर्नल्स को अधिक पाठक और उद्धरण मिल रहे हैं
700 जर्नल और 15,000,000 पाठक प्रत्येक जर्नल को 25,000+ पाठक मिल रहे हैं

में अनुक्रमित
  • गूगल ज्ञानी
  • RefSeek
  • हमदर्द विश्वविद्यालय
  • ईबीएससीओ एज़
  • आईसीएमजेई
इस पृष्ठ को साझा करें

अमूर्त

A Brief Review of Immunosenescence Aging and the Decline of Immune Function

Chuying Chen

Immunosenescence refers to the age-related deterioration of the immune system, which leads to a decline in immune function and an increased susceptibility to infections, autoimmune diseases, and malignancies. This review provides a brief overview of immunosenescence, highlighting the key mechanisms involved and the consequences for overall health in the elderly population. The immune system undergoes numerous changes during the aging process, including alterations in both innate and adaptive immunity. These changes involve structural and functional modifications in immune cells, such as reduced production of naive T cells, impaired antigen presentation, and dysregulation of cytokine signaling. Additionally, chronic low-grade inflammation, known as inflammaging, is a characteristic feature of immunosenescence, further exacerbating immune dysfunction. The decline in immune function associated with immunosenescence has profound implications for health in older individuals. Age-related immune dysfunction contributes to an increased susceptibility to infectious diseases, including respiratory tract infections, influenza, and pneumonia. Moreover, the incidence and severity of autoimmune disorders, such as rheumatoid arthritis and systemic lupus erythematosus, are higher in the elderly population. Additionally, the decline in immune surveillance leads to an elevated risk of developing malignancies and reduced efficacy of vaccination.